Authors: Ten Hagen, TLM Seynhaeve, ALB Van Tiel, ST Ruiter, DJ Eggermont, AMM

Citation: Tlm. Ten Hagen et al., Pegylated liposomal tumor necrosis factor-alpha results in reduced toxicity and synergistic antitumor activity after systemic administration in combination with liposomal doxorubicin (Doxil (R)) in soft tissue sarcoma-bearing rats, INT J CANC, 97(1), 2002, pp. 115-120

Authors: Kim, DW Andres, ML Li, J Kajioka, EH Miller, GM Seynhaeve, ALB Ten Hagen, TLM Gridley, DS

Citation: Dw. Kim et al., Liposome-encapsulated tumor necrosis factor-alpha enhances the effects of radiation against human colon tumor xenografts, J INTERF CY, 21(11), 2001, pp. 885-897

Authors: Ten Hagen, TLM Van Der Veen, AH Nooijen, PTGA Van Tiel, ST Seynhaeve, ALB Eggermont, AMM

Citation: Tlm. Ten Hagen et al., Low-dose tumor necrosis factor-alpha augments antitumor activity of stealth liposomal doxorubicin (Doxil (R)) in soft tissue sarcoma-bearing rats, INT J CANC, 87(6), 2000, pp. 829-837

Authors: de Wilt, JHW Manusama, ER van Etten, B van Tiel, ST Jorna, AS Seynhaeve, ALB ten Hagen, TLM Eggermont, AMM

Citation: Jhw. De Wilt et al., Nitric oxide synthase inhibition results in synergistic anti-tumour activity with melphalan and tumour necrosis factor alpha-based isolated limb perfusions, BR J CANC, 83(9), 2000, pp. 1176-1182

Authors: van der Veen, AH de Wilt, JHW Eggermont, AMM van Tiel, ST Seynhaeve, ALB ten Hagen, TLM

Citation: Ah. Van Der Veen et al., TNF-alpha augments intratumoural concentrations of doxorubicin in TNF-alpha-based isolated limb perfusion in rat sarcoma models and enhances anti-tumour effects, BR J CANC, 82(4), 2000, pp. 973-980

Authors: van der Veen, AH Seynhaeve, ALB Breurs, J Nooijen, PTGA Marquet, RL Eggermont, AMM

Citation: Ah. Van Der Veen et al., In vivo isolated kidney perfusion with tumour necrosis factor alpha (TNF-alpha) in tumour-bearing rats, BR J CANC, 79(3-4), 1999, pp. 433-439